Diabetes. Elevated blood glucose level
Conditions
Interventions
Intervention 1: The sample number of 36 people with diabetes of both sexes in the age range of 30 to 60 was selected in treatment group. In this way, during 4 days, the treatment center was referred,
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Have Type 2 diabetes and the use of oral hypoglycemic drugs are approved by a doctor No insulin injection Have a history of at least 2 years of diabetes Have an age range between 30 and 60 years Have taken oral hypoglycemic drugs at least three months ago The patient's body mass index is less than 30 There are no restrictions on the use of traditional medicine herbs To be willing to participate in research Be of Iranian origin Do not use other methods of traditional medicine (such as herbal medicine, massage, exercise, yoga, etc.) Have a phone number to call
Exclusion criteria
Exclusion criteria: The woman is pregnant. During lactation The patient's glycosylated hemoglobin in the last three months is 5.5-6.5%
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: Measurement of fasting blood sugar levels at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: laboratory kit.;Glycosylated hemoglobin. Timepoint: Measurement of glycosylated hemoglobin levels at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: laboratory kit.;Cholesterol. Timepoint: Measurement of cholesterol concentration at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: laboratory kit.;Quality of life. Timepoint: Measurement of quality of life at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: Diabetes-dependent quality of life questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index. Timepoint: Measurement of body mass index at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: Weight measurement using a digital scale and height measurement using a meter (BMI = kg/m2).;Systolic blood pressure. Timepoint: Measurement of systolic blood pressure at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: Digital sphygmomanometer.;Diastolic blood pressure. Timepoint: Measurement of diastolic blood pressure at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: Digital sphygmomanometer.;Triglyceride. Timepoint: Measurement of triglyceride concentration at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: laboratory kit.;High-density lipoprotein. Timepoint: Measurement of high-density lipoprotein concentration at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: laboratory kit.;Low-density lipoprotein. Timepoint: Measurement of low-density lipoprotein concentration at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: laboratory kit.;Hepatic enzyme aspartate aminotransferase. Timepoint: Measurement of hepatic enzyme aspartate aminotransferase levels at the beginning of the study (before the start of the intervention) and three months after the start of Eryngium billardieri hydrosol consumption. Method of measurement: laboratory kit.;Hepatic enzyme ala | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFakhri Sabouhi
Esfahan University of Medical Sciences
Outcome results
None listed